FIGURE 3
FROM:
Caspase-3 activation in systemic anaplastic large-cell lymphoma
Elias Drakos, George Z Rassidakis, Raymond Lai, Marco Herling, Sean L O'Connor, Annette Schmitt-Graeff, Timothy J McDonnell and L Jeffrey Medeiros
BACK TO ARTICLEFigure 3.

Caspase-3 activity as assessed in SU-DHL-1 cells treated with 5
M of doxorubicin for 6 h. Treatment of SU-DHL-1 cells with doxorubicin resulted in significant increase of caspase-3 enzymatic activity, whereas the latter remained at the levels of control SU-DHL-1 cells after addition of either DEVD-FMK or Boc-D-FMK.
